Sign In
Buy UTMD
$70.52
+0.95 (+1.37%)
At Close: Jul 31, 2026
UTMD Reports Year 2024 and Fourth Quarter Financial Performance
09:00am, Tuesday, 28'th Jan 2025
SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) c
Utah Medical Products: Favorably Skewed Risk/Reward Profile
06:33am, Thursday, 26'th Dec 2024
UTMD has been punished in 2024 despite high-quality business fundamentals and attractive valuation metrics. UTMD's economic characteristics are strong, with high post-tax margins and returns on capita
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
10:00am, Tuesday, 05'th Nov 2024
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, wh
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales
01:16pm, Wednesday, 30'th Oct 2024
UTMD reports a 5.2% EPS decline in Q3 2024, with revenues declining 20% due to reduced OEM and Filshie sales. Cost controls helped stabilize profit margins.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
09:00am, Tuesday, 29'th Oct 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were w
Utah Medical Products, Inc. Announces Quarterly Dividend
10:00am, Friday, 02'nd Aug 2024
SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share o
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales
02:46pm, Friday, 26'th Jul 2024
Utah Medical (UTMD) reports a 19.2% revenue decline in 2Q24, with EPS down 15.3% due to lower sales to major customers. Despite this, profit margins remained stable.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
09:00am, Thursday, 25'th Jul 2024
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results wh
Zacks Initiates Coverage of UTMD With Neutral Recommendation
10:16am, Tuesday, 28'th May 2024
Explore why Zacks rates UTMD with a "Neutral" recommendation, being the first on Wall Street to initiate coverage on the stock. Learn about UTMD's financial stability, diverse product portfolio, and m
Utah Medical Products, Inc. Announces Quarterly Dividend
10:00am, Tuesday, 07'th May 2024
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of c
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
09:00am, Thursday, 25'th Apr 2024
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously annou
Utah Medical Products, Inc. Announces Quarterly Dividend
10:00am, Tuesday, 06'th Feb 2024
SALT LAKE CITY, UT / ACCESSWIRE / February 6, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
09:00am, Tuesday, 30'th Jan 2024
SALT LAKE CITY, UT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTM
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
10:00am, Tuesday, 31'st Oct 2023
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
09:00am, Thursday, 26'th Oct 2023
SALT LAKE CITY, UT, Oct. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for n
